Why the study?
Does intravenous pimobendan improve hemodynamic parameters in patients with left ventricular dysfunction and moderate congestive heart failure?
Population
9 patients with left ventricular dysfunction and moderate congestive heart failure
Comparison
Intravenous administration of 5 mg of pimobendan… vs Baseline measurements before drug administration
Design
Cohort
Follow-up
60 minutes
Authors
Loading...
May support acute hemodynamic use in moderate HF; leaves open outcome benefits pending randomized trials.
Does intravenous pimobendan improve hemodynamic parameters in patients with left ventricular dysfunction and moderate congestive heart failure?
Intravenous pimobendan provides immediate and sustained improvement in left ventricular pump function and filling pressures through vasodilating, inotropic, and lusitropic effects in patients with moderate heart failure.
Remme et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: